MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
602.70%
Quick Ratio
602.70%
Cash Ratio
468.22%
Debt to Asset Ratio
16.59%
Unit: Dollar
Assets Breakdown
    • Cash and cash equivalents
    • Prepaid expenses and other curre...
    • Restricted cash
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accounts payable and accrued lia...
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
11,331,023
14,915,519
16,068,048
17,589,978
Restricted cash
591,309
723,136
974,799
1,352,975
Prepaid expenses and deposits
-
-
658,750
1,126,724
Prepaid expenses and other current assets
1,043,676
418,053
-
-
Other receivables
1,619,477
1,377,300
1,369,400
1,665,153
Total current assets
14,585,485
17,434,008
19,070,997
21,734,830
Total assets
14,585,485
17,434,008
19,070,997
21,734,830
Accounts payable and accrued liabilities
1,023,917
1,913,685
1,299,384
1,664,647
Related party payable
804,795
1,001,229
-
328,315
Deferred revenue
-
-
974,799
1,352,975
Deferred grant income
591,309
723,136
-
-
Total current liabilities
2,420,021
3,638,050
2,274,183
3,345,937
Total liabilities
2,420,021
3,638,050
2,274,183
3,345,937
Common stock, 0.001 par value, 130 million shares authorized, 16.7 million shares issued and outstanding as of june 30, 2026 and december 31, 2025, respectively (see note 8)
16,672
16,672
16,672
16,672
Additional paid-in capital
476,335,097
476,139,362
475,960,940
475,849,809
Accumulated deficit
-464,186,305
-462,360,076
-459,180,798
-457,477,588
Total stockholders' equity
12,165,464
13,795,958
16,796,814
18,388,893
Total liabilities and stockholders' equity
14,585,485
17,434,008
19,070,997
21,734,830
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$11,331,023 (8.31%↑ Y/Y)Other receivables$1,619,477 (-3.28%↓ Y/Y)Prepaid expenses andother current assets$1,043,676 Restricted cash$591,309 (-56.30%↓ Y/Y)Total current assets$14,585,485 (-1.24%↓ Y/Y)Total assets$14,585,485 (-1.24%↓ Y/Y)Total liabilities andstockholders' equity$14,585,485 (-1.24%↓ Y/Y)Total stockholders'equity$12,165,464 (15.97%↑ Y/Y)Total liabilities$2,420,021 (-43.42%↓ Y/Y)Accumulated deficit-$464,186,305 (-1.91%↓ Y/Y)Additional paid-in capital$476,335,097 (2.23%↑ Y/Y)Total currentliabilities$2,420,021 (-43.42%↓ Y/Y)Common stock, 0.001 parvalue, 130 million...$16,672 (47.37%↑ Y/Y)Accounts payable andaccrued liabilities$1,023,917 (-54.85%↓ Y/Y)Related party payable$804,795 (22.56%↑ Y/Y)Deferred grant income$591,309

Marker Therapeutics, Inc. (MRKR)

Marker Therapeutics, Inc. (MRKR)